CarePass: Verified ADHD Treatment Continuity Verification & Documentation Vault
Relocating ADHD patients face an abrupt reset of their psychiatric care. New out-of-state providers frequently ignore previous medical histories, requiring costly re-evaluations from scratch and making stable patients feel judged as 'drug-seeking' or a 'fiend' when requesting continuity of their prescription.
Is the problem real?
Patients moving to a new state face a complete reset of their established ADHD care and must navigate skeptical providers who treat them as drug-seeking rather than continuing a functional, long-term treatment plan.
EVIDENCE
Moving states + restarting ADHD treatment has been way harder than expected
I also don’t wanna it to look like I’m fishing for a prescription for abuse or recreational use.
postMoving states + restarting ADHD treatment has been way harder than expected
It does seem kind of silly to have to reinvent the wheel.
commentIt does make sense to have your prior provider give you notes that you could pass on to your current provider in Virginia. It does seem kind of silly to have to reinvent the wheel.
Yes bro same issue and don’t wanna look like a fein lol
commentYes bro same issue and don’t wanna look like a fein lol
Who feels this pain?
TARGET USERS
Patients moving to a new state who need to quickly transfer their established controlled medication history to a new local psychiatrist without facing skepticism or treatment disruption.
Context
Current Workarounds
Where's the gap?
EXISTING SOLUTION GAPS
OPPORTUNITY & VALUE
Repeated complaints focus heavily on the anxiety around clinical bias (being seen as drug-seeking) and the frustration of having to fully restart medical diagnosis evaluations upon moving.
Unlike broad patient portals or EHRs, this is explicitly structured to combat the 'drug-seeking' bias for controlled substances by framing continuity around long-term longitudinal compliance, stability data, and verified history.
A dedicated documentation platform and continuity passport that aggregates prior psychiatric evaluations, pharmacy dispensing logs, and longitudinal adherence evidence into a standardized, compliance-ready 'Clinical Care Packet' that new out-of-state providers can easily verify and rely on to fast-track onboarding.
How does it make money?
MONETIZATION
Model
Users face hundreds of dollars in out-of-pocket costs for redundant psychological re-evaluations, alongside severe anxiety about losing access to their medication. A one-time fee to prevent a total care reset provides instant ROI.
How do you ship it?
MVP PLAN
“Keep your ADHD care plan intact when moving to a new state.”
A dedicated documentation platform and continuity passport that aggregates prior psychiatric evaluations, pharmacy dispensing logs, and longitudinal adherence evidence into a standardized, compliance-ready 'Clinical Care Packet' that new out-of-state providers can easily verify and rely on to fast-track onboarding.
Core Features
Weekly Roadmap
- •Set up encrypted storage bucket and user onboarding flow
- •Create a standardized PDF template optimized for clinical intake
- •Build basic manual upload workflow for existing medical PDFs
- •Integrate digital fax/secure email API to transmit packets to clinics
- •Incorporate a basic directory database of known provider offices
- •Develop authorization/consent flow to release records cleanly
- •Integrate Stripe for one-time payment handling
- •Conduct security and compliance sanity review for medical data
- •Onboard 10 beta users from target online communities to generate reports
- •Publish resource guides and launch tool on r/ADHD and moving networks
- •Gather feedback from first set of receiving provider offices
- •Analyze report delivery success rate and conversion data
Target online communities and relocation channels (r/ADHD, r/moving, regional subreddits, and ADHD support groups) where patients explicitly seek advice on out-of-state provider navigation.
RISKS & ASSUMPTIONS
Top Risks
New psychiatrists may refuse to alter their default clinical onboarding procedures or review the packet due to strict liability and licensing fears.
Handling sensitive psychiatric diagnoses and controlled substance histories demands rigorous security infrastructure and legal compliance from day one.
Relocation is a episodic event, meaning customer lifetime value may be limited unless expanded to broader continuity needs.
Should you build it?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 8/10 against 4 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for Other founders
It sits at the intersection of "adhd-care", "compliance", "data-management", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. Opportunities in this category typically reward founders who can describe the pain in the user's own language — both because that's the basis of effective marketing, and because it's the strongest signal that the founder has done the upfront listening. The MonetScope pipeline surfaces this category alongside other other signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "CarePass: Verified ADHD Treatment Continuity Verification & Documentation Vault" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd-care?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most other opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.